DE3778723D1 - Leicht absorbierbare pharmazeutische zubereitung. - Google Patents
Leicht absorbierbare pharmazeutische zubereitung.Info
- Publication number
- DE3778723D1 DE3778723D1 DE8787101664T DE3778723T DE3778723D1 DE 3778723 D1 DE3778723 D1 DE 3778723D1 DE 8787101664 T DE8787101664 T DE 8787101664T DE 3778723 T DE3778723 T DE 3778723T DE 3778723 D1 DE3778723 D1 DE 3778723D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical preparation
- easily absorbable
- absorbable pharmaceutical
- preparation
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61026589A JPS62185013A (ja) | 1986-02-08 | 1986-02-08 | 易吸収性医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3778723D1 true DE3778723D1 (de) | 1992-06-11 |
Family
ID=12197726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8787101664T Expired - Lifetime DE3778723D1 (de) | 1986-02-08 | 1987-02-06 | Leicht absorbierbare pharmazeutische zubereitung. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5002952A (de) |
| EP (1) | EP0233559B1 (de) |
| JP (1) | JPS62185013A (de) |
| CA (1) | CA1281652C (de) |
| DE (1) | DE3778723D1 (de) |
| ES (1) | ES2033701T3 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4983605A (en) * | 1986-10-23 | 1991-01-08 | Ishihara Sangyo Kaisha Ltd. | Pharmaceutical composition |
| GB8629481D0 (en) * | 1986-12-10 | 1987-01-21 | Beecham Group Plc | Veterinary treatment |
| JP2764274B2 (ja) * | 1988-03-28 | 1998-06-11 | 株式会社ミドリ十字 | 医薬組成物 |
| JPH01299226A (ja) * | 1988-05-27 | 1989-12-04 | Seikagaku Kogyo Co Ltd | サラゾスルファピリジン腸溶顆粒 |
| JPH023609A (ja) * | 1988-06-21 | 1990-01-09 | Fujimoto Seiyaku Kk | 塩酸ニカルジピンを活性成分とする持効性製剤 |
| JPH0278699A (ja) * | 1988-09-12 | 1990-03-19 | Green Cross Corp:The | ベンゾイルウレア系化合物・アルブミン複合体 |
| JPH02237922A (ja) * | 1989-01-24 | 1990-09-20 | Green Cross Corp:The | 抗ウィルス剤 |
| JP2773895B2 (ja) * | 1989-04-25 | 1998-07-09 | 東京田辺製薬株式会社 | ダナゾール組成物 |
| US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| EP0810853B1 (de) * | 1995-02-24 | 2004-08-25 | Elan Pharma International Limited | Nanopartikel-dispersionen enthaltende aerosole |
| US5834025A (en) | 1995-09-29 | 1998-11-10 | Nanosystems L.L.C. | Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
| US20030199425A1 (en) * | 1997-06-27 | 2003-10-23 | Desai Neil P. | Compositions and methods for treatment of hyperplasia |
| US8236352B2 (en) * | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
| US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
| US20080213378A1 (en) * | 1998-10-01 | 2008-09-04 | Elan Pharma International, Ltd. | Nanoparticulate statin formulations and novel statin combinations |
| EP1117384A1 (de) * | 1998-10-01 | 2001-07-25 | Elan Pharma International Limited | Nanopartikelformulierungen mit kontrollierter wirkstofffreisetzung |
| US6969529B2 (en) | 2000-09-21 | 2005-11-29 | Elan Pharma International Ltd. | Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
| US6428814B1 (en) | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| US20040141925A1 (en) * | 1998-11-12 | 2004-07-22 | Elan Pharma International Ltd. | Novel triamcinolone compositions |
| US7521068B2 (en) | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
| EP2298311B1 (de) | 1999-01-13 | 2012-05-09 | Bayer HealthCare LLC | Omega-carboxyarylsubstituierte-Diphenyl-Harnstoffe als p38-Kinasehemmer |
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US20040115134A1 (en) * | 1999-06-22 | 2004-06-17 | Elan Pharma International Ltd. | Novel nifedipine compositions |
| US6656504B1 (en) | 1999-09-09 | 2003-12-02 | Elan Pharma International Ltd. | Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| US7198795B2 (en) | 2000-09-21 | 2007-04-03 | Elan Pharma International Ltd. | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions |
| US20030129242A1 (en) * | 2002-01-04 | 2003-07-10 | Bosch H. William | Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
| US20030216396A1 (en) | 2002-02-11 | 2003-11-20 | Bayer Corporation | Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors |
| MXPA04007832A (es) | 2002-02-11 | 2005-09-08 | Bayer Pharmaceuticals Corp | Aril-ureas con actividad inhibitoria de angiogenesis. |
| ES2378670T3 (es) | 2002-02-11 | 2012-04-16 | Bayer Healthcare, Llc | Aril ureas como inhibidores de cinasas |
| CA2479665C (en) * | 2002-03-20 | 2011-08-30 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
| US7557129B2 (en) | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| JP2004323387A (ja) * | 2003-04-23 | 2004-11-18 | Taisho Pharmaceut Co Ltd | ソファルコン含有固形製剤 |
| ATE366108T1 (de) | 2003-05-20 | 2007-07-15 | Bayer Pharmaceuticals Corp | Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten |
| UA84156C2 (ru) | 2003-07-23 | 2008-09-25 | Байер Фармасьютикалс Корпорейшн | Фторозамещённая омега-карбоксиарилдифенилмочевина для лечения и профилактики болезней и состояний |
| EP1923051A4 (de) * | 2005-09-06 | 2012-12-19 | Astellas Pharma Inc | Mikroteilchen einer schwerlöslichen substanz mit enterischem basismaterial, das auf der oberfläche der substanz adsorbiert ist |
| US20090099218A1 (en) * | 2007-09-17 | 2009-04-16 | Khan Saeed R | Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5640667A (en) * | 1979-09-11 | 1981-04-16 | Ishihara Sangyo Kaisha Ltd | Urea derivative |
| AU1862083A (en) * | 1982-09-02 | 1984-03-08 | Duphar International Research B.V. | Tumor growth inhibitors |
| NZ212208A (en) * | 1984-06-15 | 1988-04-29 | Ishihara Sangyo Kaisha | N-benzoyl-n'-pyrimidinyloxyphenyl ureas and pharmaceutical compositions |
| JPS6193163A (ja) * | 1984-10-12 | 1986-05-12 | Ishihara Sangyo Kaisha Ltd | Ｎ−ベンゾイル−ｎ′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤 |
| US4727077A (en) * | 1985-02-20 | 1988-02-23 | Ishihara Sangyo Kaisha Ltd. | Benzoyl urea compounds, process for their production, and antitumorous compositions containing them |
| AU594098B2 (en) * | 1985-12-11 | 1990-03-01 | Ishihara Sangyo Kaisha Ltd. | N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation |
-
1986
- 1986-02-08 JP JP61026589A patent/JPS62185013A/ja active Pending
-
1987
- 1987-02-06 DE DE8787101664T patent/DE3778723D1/de not_active Expired - Lifetime
- 1987-02-06 CA CA000529230A patent/CA1281652C/en not_active Expired - Lifetime
- 1987-02-06 EP EP87101664A patent/EP0233559B1/de not_active Expired - Lifetime
- 1987-02-06 ES ES198787101664T patent/ES2033701T3/es not_active Expired - Lifetime
-
1989
- 1989-07-27 US US07/385,998 patent/US5002952A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5002952A (en) | 1991-03-26 |
| EP0233559B1 (de) | 1992-05-06 |
| CA1281652C (en) | 1991-03-19 |
| JPS62185013A (ja) | 1987-08-13 |
| EP0233559A1 (de) | 1987-08-26 |
| ES2033701T3 (es) | 1993-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3778723D1 (de) | Leicht absorbierbare pharmazeutische zubereitung. | |
| DE68901417D1 (de) | Pharmazeutische zusammensetzung. | |
| DE3863963D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE3868986D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE122004000023I2 (de) | Pharmazeutische Zusammensetzung | |
| DE69101931T2 (de) | Pharmazeutische Zusammensetzung. | |
| DK489189D0 (da) | Farmaceutisk praeparat | |
| DE3781034D1 (de) | Topische pharmazeutische zubereitung mit besserer durchdringungsfaehigkeit. | |
| DE69006094D1 (de) | Pharmazeutische Zusammensetzungen. | |
| DE3682083D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE68905573D1 (de) | Leicht absorbierbare nb-818 enthaltende arzneizubereitung. | |
| DE3674040D1 (de) | Pharmazeutische zusammensetzungen. | |
| DK603988D0 (da) | Farmaceutisk praeparat | |
| FI874382A (fi) | Farmaceutiska preparat. | |
| DK336489A (da) | Farmaceutisk praeparat | |
| DE68915203D1 (de) | Pharmazeutische Mischungen. | |
| DE3866789D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE58905160D1 (de) | Pharmazeutische zubereitung. | |
| FI875616A0 (fi) | Farmaceutiska blandningar. | |
| DE68902056D1 (de) | 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung. | |
| DE3768109D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE69003003D1 (de) | Pharmazeutische Zusammensetzung. | |
| DE3667915D1 (de) | Pharmazeutische zusammensetzung. | |
| DK638889D0 (da) | Farmaceutisk kombinationspraeparat | |
| PT85350B (de) | Xylometazolinhaltige pharmazeutische praeparate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |